Associate Director/Director, Clinical Operations Excellence
City Therapeutics
Summary
City Therapeutics is a biopharmaceutical company harnessing next-generation engineering to improve and expand the reach of RNAi-based medicines. The company is building a pipeline of innovative RNAi therapeutics to make a significant impact for patients across multiple therapeutic areas.
Job description
We are seeking a highly motivated Associate Director/Director of Clinical Operations Excellence.
Key Responsibilities
SOP Development and Process Improvement
- Own the clinical operations SOP, work instruction and template framework, including authoring, review, approval and periodic review cycles
- Map and simplify end-to-end clinical processes (study start-up, monitoring oversight, vendor oversight, close-out), removing duplication and handoffs
- Align SOPs with ICH E6(R3), FDA, EMA/EU-CTR and other applicable regulations, and update them as guidance changes
- Define and lead the roadmap for AI and automation in clinical operations (e.g., TMF document classification and QC, protocol and SOP drafting support, risk-based monitoring analytics, CRO budget and invoice review)
- Build AI literacy across the clinical team through training and practical guidance
Trial Master File
- Own the TMF strategy, eTMF system and TMF Plan for all sponsored studies, using the DIA TMF Reference Model
- Set TMF quality, completeness and timeliness metrics; run periodic TMF health checks and drive remediation with study teams and CROs
- Oversee CRO-held TMFs, including the transfer, reconciliation and archiving of sponsor TMFs at study closes
- Make sure the TMF tells the story of each trial and is ready for inspection at any point in the study lifecycle
Clinical Quality Compliance
- Partner with QA and other Development functions to run the clinical quality management framework, including risk-based quality management (RBQM) under ICH E6(R3)
- Partner with QA on clinical quality issue documentation and CAPA management, including root cause analysis and effectiveness checks
- Track and report quality KPIs and trends to Clinical Operations leadership
Inspection Readiness
- Lead Clinical inspection readiness programs for regulatory inspections and sponsor audits by partnering with the study teams to review documentation, adherence to SOPs and plans, storyboard creations and study oversight practices
- Assist with mock inspections and interview preparation for study teams
- Partner with QA on the audit program and make sure audit findings are closed on time
GDPR Data Privacy
- Act as Clinical liaison with City's GDPR Data Privacy officer
- Work with study teams to plan and implement data privacy impact assessments, review of documents and other elements required for compliance in GDPR regions
Qualifications
- 10+ years in clinical research in biotech, pharma or a CRO, with at least 5 years in clinical operations, clinical quality or process excellence roles
- Hands-on ownership of eTMF systems including TMF oversight of CRO-run studies
- Proven record writing and implementing clinical SOPs and controlled documents
- Deep working knowledge of ICH E6(R3) GCP, 21 CFR, and EU-CTR
- Experience with deviation and CAPA management and root cause analysis
- Strong writing, facilitation and stakeholder skills, including influencing without direct authority
- Understanding of Data Privacy regulations and experience liaising with Data Privacy Officer
Preferred Qualifications
- Direct experience preparing for and hosting at least one regulatory inspection
- Experience leading technology or process change projects, with a working understanding of AI and automation tools and their validation requirements
- Experience at a small to mid-size sponsor that outsources to CROs, building processes from the ground up
Requirements
- 10+ years in clinical research in biotech, pharma or a CRO
- At least 5 years in clinical operations, clinical quality or process excellence roles
- Hands-on ownership of eTMF systems including TMF oversight of CRO-run studies
- Proven record writing and implementing clinical SOPs and controlled documents
- Deep working knowledge of ICH E6(R3) GCP, 21 CFR, and EU-CTR
- Experience with deviation and CAPA management and root cause analysis
- Strong writing, facilitation and stakeholder skills, including influencing without direct authority
- Understanding of Data Privacy regulations and experience liaising with Data Privacy Officer
Benefits
- Annual Bonus
- Equity Compensation
- Competitive Benefits Package
Company overview
City Therapeutics is a pioneering biotechnology company focused on advancing next-generation RNA interference (RNAi) therapeutics. Founded in 2024 by leading executives and scientists from the RNAi field, including former Alnylam Pharmaceuticals CEO John Maraganore, the company is headquartered in Cambridge, Massachusetts. City Therapeutics specializes in engineering small interfering RNAs (siRNAs) to create innovative medicines that can silence gene expression and block protein production for treating various diseases. The company has raised $135 million in Series A funding from prominent investors including ARCH Venture Partners, Fidelity Management & Research Company, and Regeneron Ventures. City Therapeutics is developing a sustainable product engine for RNAi-based medicines, with its lead program CITY-FXI targeting Factor XI for thromboembolic diseases expected to enter clinical trials. The company's platform focuses on designing novel RNAi triggers with improved potency and specificity, developing tailored targeting ligands for broader tissue delivery, and creating best-in-class molecules to expand RNAi's therapeutic reach beyond the liver to address ocular, CNS, and other tissue types.